Carrot Expands Network of High-Performing Fertility Providers
WEST DES MOINES, Iowa, Aug. 4, 2025 /PRNewswire/ -- Carrot today announced a major expansion to its nationwide network of high-performance clinics and providers with 4,200 new contracts across all 50 states. To complement this growth, Carrot's robust managed fertility clinic network now offers greater flexibility with payments for customers and a more seamless care experience for members.
'Each year, Carrot makes important investments to strengthen our managed network, elevating and evolving the experience for members, customers, and providers,' said James Wong, Carrot's Chief Outcomes Officer. 'In 2025, we made large investments to build on our strong foundation across three key areas: access, payments, and quality. Together, these changes mean even more access, better member experiences, and outstanding clinical outcomes for Carrot customers.'
Key managed network expansions include:
This network expansion builds on Carrot's momentum in redefining fertility care through a comprehensive, root-cause approach. The company recently announced Sprints, a groundbreaking program that directly targets conditions related to metabolic dysfunction. Together with this network expansion, these advances further enable Carrot to deliver hyper-personalized care by connecting members with top-performing clinics while addressing underlying health factors that affect fertility and pregnancy outcomes.
'Maintaining the best-in-class network isn't just about identifying top performing providers – it's about ensuring that every member receives the highest quality, evidence-based care at the right time, in the right setting, and with clear financial transparency,' said Dr. Asima Ahmad, Carrot's Chief Medical Officer. 'By guiding members individually, Carrot is continuing to improve results, reduce unnecessary and expensive care, and elevate the entire standard of care for fertility.'
About Carrot
Carrot is the leading global fertility and family care platform, unlocking support for life's major moments. Trusted by more than 1,000 of the world's best multinational employers, health plans and health systems, Carrot's comprehensive clinical program delivers industry-leading cost savings for employers and exceptional experiences for millions of employees. Its award-winning product serves all populations, whether there is a need for preconception care, pregnancy, IVF, male factor infertility, adoption, gestational carrier care or menopause, Carrot supports members and their families through many of the most memorable and meaningful moments of their lives.
Carrot has received national and international recognition for its pioneering work, including Fast Company's 'Most Innovative Companies,' CNBC's '100 Barrier Breaking Startups' and more. Carrot is regularly featured in media reporting on issues related to the future of work, women in leadership, and healthcare innovation; such as The Economist, Bloomberg, Elle Magazine (Japanese edition), The Wall Street Journal, ABC, CNBC, National Public Radio, Harvard Business Review and more.
View original content to download multimedia: https://www.prnewswire.com/news-releases/carrot-expands-network-of-high-performing-fertility-providers-302520303.html
SOURCE Carrot Fertility, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
3 minutes ago
- Bloomberg
Corporate Credit Markets Are Flashing Signs of Complacency, UBS Says
Corporate credit markets in the US are exhibiting greater signs of complacency than the stock market by one key measure, as debt valuations approach multidecade highs, according to UBS. Risk premiums in the US high-yield market — which measure the extra yield investors demand to hold that debt instead of Treasuries — are hovering less than half a percentage point above their 10-year low. By the bank's calculations, investors in those bonds are suggesting global economic growth of more than 5% this year, which is higher than what most other markets imply, UBS strategists, including Matthew Mish, wrote Monday.
Bloomberg
3 minutes ago
- Bloomberg
FDA Chief Says He Wants Gene Therapy Head Prasad to Return
By and Skylar Woodhouse Save US Food and Drug Administration Commissioner Marty Makary said he's trying to persuade Vinay Prasad, the agency's former head of gene therapy and vaccines, to return to the FDA after his abrupt departure last week. Makary told reporters Monday that media reports suggesting that Prasad was fired after intervention from the White House are 'simply untrue.' He 'didn't want to be a distraction,' Makary said.
Bloomberg
25 minutes ago
- Bloomberg
Stock Movers: Palantir, Hims & Hers, ON Semi
On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Scarlet Fu, Carol Massar and Matt Miller. - Palantir (PLTR) reported a 48% increase in revenue for the second quarter to more than $1 billion, citing the 'astonishing impact' of artificial technology on its business. The data software company also raised its revenue outlook for the full year to $4.14 billion to $4.15 billion, exceeding analysts' prior expectation of $3.91 billion. Denver-based Palantir has seen its stock price surge more than 500% over the past year — buoyed by high expectations from investors, growth in demand for AI tools and a deep reach into both the private and public sectors. Shares rose in afterhours trading. - Hims & Hers (HIMS) reported revenue for the second quarter that missed the average analyst estimate. The San Francisco-based company recorded sales of $545 million for the three months ended June 30, according to a statement, below Wall Street's average estimate of $552 million. It reaffirmed its full-year revenue guidance of $2.3 billion to $2.4 billion. Shares dropped in post-market trading. - ON Semi (ON) reported adjusted earnings per share for the second quarter that matched the average analyst estimate.
